Log In
Print
BCIQ
Print
Print this Print this
 

Amanden

  Manage Alerts
Collapse Summary General Information
Company Amyndas Pharmaceuticals S.A.
DescriptionCompstatin-derived synthetic peptide that binds and inhibits complement 3 (C3)
Molecular Target Complement 3 (C3)
Mechanism of ActionComplement inhibitor
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPreclinical
Standard IndicationRenal transplant
Indication DetailsPrevent rejection in ABO-incompatible kidney transplant recipients
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today